No abstract available
MeSH terms
-
Adult
-
Aged
-
Antibodies, Viral / blood*
-
BNT162 Vaccine
-
Belgium
-
COVID-19 / immunology
-
COVID-19 / prevention & control*
-
COVID-19 / virology
-
COVID-19 Vaccines / administration & dosage*
-
Female
-
Humans
-
Immunity, Humoral / drug effects
-
Immunization Schedule
-
Immunocompromised Host
-
Immunogenicity, Vaccine*
-
Immunosuppressive Agents / adverse effects
-
Interferon-gamma / metabolism
-
Kidney Transplantation / adverse effects*
-
Lymphocyte Activation / drug effects
-
Male
-
Middle Aged
-
Prospective Studies
-
SARS-CoV-2 / immunology*
-
SARS-CoV-2 / pathogenicity
-
Spike Glycoprotein, Coronavirus / immunology*
-
T-Lymphocytes / drug effects*
-
T-Lymphocytes / immunology
-
T-Lymphocytes / metabolism
-
T-Lymphocytes / virology
-
Time Factors
-
Vaccination*
Substances
-
Antibodies, Viral
-
COVID-19 Vaccines
-
IFNG protein, human
-
Immunosuppressive Agents
-
Spike Glycoprotein, Coronavirus
-
spike protein, SARS-CoV-2
-
Interferon-gamma
-
BNT162 Vaccine